Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Oncology
Reference28 articles.
1. Chew W, Benson C, Thway K, Hayes A, Miah A, Zaidi S, et al. Clinical characteristics and efficacy of chemotherapy in sclerosing epithelioid fibrosarcoma. Med Oncol. 2018;35(11):138–44. https://doi.org/10.1007/s12032-018-1192-6.
2. Evans HL. Low-grade fibromyxoid sarcoma. (1987) A report of two metastasizing neoplasms having a deceptively benign appearance. Am J Clin Pathol 88(5):615–619. https://doi.org/10.1093/ajcp/88.5.615.
3. Fletcher C, Bridge J, Hogendoorn P, et al. (2013) World Health Organization classification of tumours of soft tissue and bone: pathology and genetics of tumours of soft tissue and bone, 4th ed. Lyon, France: IARC Press.
4. Meis-Kindblom JM, Kindblom LG, Enzinger FM. Sclerosing epithelioid fibrosarcoma: a variant of fibrosarcoma simulating carcinoma. Am J Surg Pathol. 1995;19(9):979–93. https://doi.org/10.1097/00000478-199509000-00001.
5. Prieto-Granada C, Zhang L, Chen HW, Sung YS, Agaram NP, Jungbluth AA, et al. A genetic dichotomy between pure sclerosing epithelioid fibrosarcoma (SEF) and hybrid SEF/low-grade fibromyxoid sarcoma: a pathologic and molecular study of 18 cases. Genes Chromosomes Cancer. 2015;54(1):28–38. https://doi.org/10.1002/gcc.22215.